Suppr超能文献

季铵拮抗剂对大鼠纹状体中多巴胺能神经末梢S-(-)-尼古丁诱发的多巴胺释放的最大抑制作用(Imax)的定量构效关系研究。

QSAR study on maximal inhibition (Imax) of quaternary ammonium antagonists for S-(-)-nicotine-evoked dopamine release from dopaminergic nerve terminals in rat striatum.

作者信息

Zheng Fang, McConnell Matthew J, Zhan Chang-Guo, Dwoskin Linda P, Crooks Peter A

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, United States.

出版信息

Bioorg Med Chem. 2009 Jul 1;17(13):4477-85. doi: 10.1016/j.bmc.2009.05.010. Epub 2009 May 8.

Abstract

Maximal inhibition (I(max)) of the agonist effect is an important pharmacological property of inhibitors that interact with multiple receptor subtypes that are activated by the same agonist and which elicit the same functional response. This report represents the first QSAR study on a set of 66 mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating nicotine-evoked dopamine release, conducted using multi-linear regression (MLR) and neural network (NN) analysis with the maximal inhibition (I(max)) values of the antagonists as target values. The statistical results for the generated MLR model were: r(2)=0.89, rmsd=9.01, q(2)=0.83 and loormsd=11.1; the statistical results for the generated NN model were: r(2)=0.89, rmsd=8.98, q(2)=0.83 and loormsd=11.2. The maximal inhibition values of the compounds exhibited a good correlation with the predictions made by the QSAR models developed, which provide a basis for rationalizing selection of compounds for synthesis in the discovery of effective and selective second generation inhibitors of nAChRs mediating nicotine-evoked dopamine release.

摘要

激动剂效应的最大抑制(I(max))是抑制剂的一项重要药理学特性,这类抑制剂可与多种受体亚型相互作用,这些受体亚型由同一激动剂激活并引发相同的功能反应。本报告是对一组66种单季铵盐和双季铵盐进行的首次定量构效关系(QSAR)研究,这些盐类作为神经元烟碱型乙酰胆碱受体的拮抗剂,介导尼古丁诱发的多巴胺释放,研究采用多元线性回归(MLR)和神经网络(NN)分析,以拮抗剂的最大抑制(I(max))值作为目标值。生成的MLR模型的统计结果为:r(2)=0.89,rmsd=9.01,q(2)=0.83,loormsd=11.1;生成的NN模型的统计结果为:r(2)=0.89,rmsd=8.98,q(2)=0.83,loormsd=11.2。化合物的最大抑制值与所开发的QSAR模型的预测结果呈现出良好的相关性,这为在发现介导尼古丁诱发多巴胺释放的有效且选择性第二代烟碱型乙酰胆碱受体(nAChRs)抑制剂时合理选择合成化合物提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c921/3914672/0a15e8b8e5d3/nihms116461f1.jpg

相似文献

本文引用的文献

9
Varenicline: progress in smoking cessation treatment.伐尼克兰:戒烟治疗的进展
Expert Opin Pharmacother. 2007 Aug;8(11):1757-67. doi: 10.1517/14656566.8.11.1757.
10
Varenicline: the newest agent for smoking cessation.伐尼克兰:最新的戒烟药物。
Am J Health Syst Pharm. 2007 Jul 1;64(13):1381-4. doi: 10.2146/ajhp060428.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验